These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38644896)

  • 1. Optimal timing for drug delivery into the hippocampus by focused ultrasound: A comparison of hydrophilic and lipophilic compounds.
    Seo Y; Chang KW; Lee J; Kong C; Shin J; Chang JW; Na YC; Chang WS
    Heliyon; 2024 Apr; 10(8):e29480. PubMed ID: 38644896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis.
    Yang YR; Xiong XY; Liu J; Wu LR; Zhong Q; Zhou K; Meng ZY; Liu L; Wang FX; Gong QW; Liao MF; Duan CM; Li J; Yang MH; Zhang Q; Gong CX; Yang QW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mfsd2a Attenuates Blood-Brain Barrier Disruption After Sub-arachnoid Hemorrhage by Inhibiting Caveolae-Mediated Transcellular Transport in Rats.
    Zhao C; Ma J; Wang Z; Li H; Shen H; Li X; Chen G
    Transl Stroke Res; 2020 Oct; 11(5):1012-1027. PubMed ID: 31907728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats.
    Zhou M; Li D; Shen Q; Gao L; Zhuang P; Zhang Y; Guo H
    Front Pharmacol; 2022; 13():876235. PubMed ID: 35873558
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability.
    Cui Y; Wang Y; Song X; Ning H; Zhang Y; Teng Y; Wang J; Yang X
    Cell Rep; 2021 Jul; 36(1):109327. PubMed ID: 34233198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis.
    Zhang Y; Wang L; Pan Q; Yang X; Cao Y; Yan J; Wang Y; Tao Y; Fan R; Sun X; Li L
    Fluids Barriers CNS; 2022 Jul; 19(1):57. PubMed ID: 35820896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
    Ju X; Miao T; Chen H; Ni J; Han L
    Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burns Impair Blood-Brain Barrier and Mesenchymal Stem Cells Can Reverse the Process in Mice.
    Yang J; Ma K; Zhang C; Liu Y; Liang F; Hu W; Bian X; Yang S; Fu X
    Front Immunol; 2020; 11():578879. PubMed ID: 33240266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles.
    Deng J; Huang Q; Wang F; Liu Y; Wang Z; Wang Z; Zhang Q; Lei B; Cheng Y
    J Mol Neurosci; 2012 Mar; 46(3):677-87. PubMed ID: 21861133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mfsd2a is critical for the formation and function of the blood-brain barrier.
    Ben-Zvi A; Lacoste B; Kur E; Andreone BJ; Mayshar Y; Yan H; Gu C
    Nature; 2014 May; 509(7501):507-11. PubMed ID: 24828040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability.
    Zhang XL; Du WH; Qian SX; Lu XD; Yu X; Fang HL; Dong JL; Song M; Sun YY; Wu XQ; Shen YF; Hao YN; Shen MH; Zhou BQ; Wang YP; Xu CY; Jin XC
    Acta Pharmacol Sin; 2024 Jun; ():. PubMed ID: 38902501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
    Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
    Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening.
    Ji R; Karakatsani ME; Burgess M; Smith M; Murillo MF; Konofagou EE
    J Control Release; 2021 Sep; 337():458-471. PubMed ID: 34324895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mfsd2a attenuated hypoxic-ischemic brain damage via protection of the blood-brain barrier in mfat-1 transgenic mice.
    Li X; Zhang Y; Chang J; Zhang C; Li L; Dai Y; Yang H; Wang Y
    Cell Mol Life Sci; 2023 Feb; 80(3):71. PubMed ID: 36820986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
    Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
    Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mfsd2a Reverses Spatial Learning and Memory Impairment Caused by Chronic Cerebral Hypoperfusion via Protection of the Blood-Brain Barrier.
    Qu C; Song H; Shen J; Xu L; Li Y; Qu C; Li T; Zhang J
    Front Neurosci; 2020; 14():461. PubMed ID: 32612494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
    Jung B; Huh H; Lee EH; Han M; Park J
    J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
    Poon C; Pellow C; Hynynen K
    Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
    [No Abstract]   [Full Text] [Related]  

  • 19. Focused Ultrasound and Microbubble Treatment Increases Delivery of Transferrin Receptor-Targeting Liposomes to the Brain.
    Olsman M; Sereti V; Mühlenpfordt M; Johnsen KB; Andresen TL; Urquhart AJ; Davies CL
    Ultrasound Med Biol; 2021 May; 47(5):1343-1355. PubMed ID: 33608142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies.
    Wasielewska JM; Chaves JCS; Johnston RL; Milton LA; Hernández D; Chen L; Song J; Lee W; Leinenga G; Nisbet RM; Pébay A; Götz J; White AR; Oikari LE
    Theranostics; 2022; 12(16):6826-6847. PubMed ID: 36276649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.